Gill John's Form 4 filing
Altimmune, Inc. (ALT) · filed Jul 6, 2023
- Accession no.
- 0001104659-23-078839
- Filed
- Jul 6, 2023
- Trade date
- Aug 12, 2022
- Filing delay
- 328 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $40.7K. It was filed 328 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gill JohnCIK 0001409939 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Common Stock, par value $0.0001 | SSaleDisposed | −2,714 | $15.00 | −$40,710 | 2,771 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.